267 related articles for article (PubMed ID: 17563304)
1. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes.
Ellis SL; Gemperline KA; Garg SK
Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304
[TBL] [Abstract][Full Text] [Related]
2. Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures.
Rosenstock J; Nakano M; Silverman BL; Sun B; de la Peña A; Suri A; Muchmore DB
Diabetes Technol Ther; 2007 Feb; 9(1):80-8. PubMed ID: 17316102
[TBL] [Abstract][Full Text] [Related]
3. The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data.
Muchmore DB; Silverman B; De La Peña A; Tobian J
Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S41-7. PubMed ID: 17563303
[TBL] [Abstract][Full Text] [Related]
4. Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system.
Hayes RP; Nakano M; Muchmore D; Schmitke J
Diabetes Technol Ther; 2007 Feb; 9(1):89-98. PubMed ID: 17316103
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes.
Garg S; Rosenstock J; Silverman BL; Sun B; Konkoy CS; de la Peña A; Muchmore DB
Diabetologia; 2006 May; 49(5):891-9. PubMed ID: 16506054
[TBL] [Abstract][Full Text] [Related]
6. Technosphere insulin technology.
Richardson PC; Boss AH
Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S65-72. PubMed ID: 17563306
[TBL] [Abstract][Full Text] [Related]
7. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
8. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
[TBL] [Abstract][Full Text] [Related]
9. Inhaled human insulin.
Strack TR
Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
[TBL] [Abstract][Full Text] [Related]
10. Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.
Rave KM; Nosek L; de la Peña A; Seger M; Ernest CS; Heinemann L; Batycky RP; Muchmore DB
Diabetes Care; 2005 Oct; 28(10):2400-5. PubMed ID: 16186270
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
Comulada AL; Renard E; Nakano M; Rais N; Mao X; Webb DM; Milicevic Z
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S17-25. PubMed ID: 19772445
[TBL] [Abstract][Full Text] [Related]
12. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
13. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
14. Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system.
Wise S; Chien J; Yeo K; Richardson C
Diabet Med; 2006 May; 23(5):510-5. PubMed ID: 16681559
[TBL] [Abstract][Full Text] [Related]
15. Inhaled dry powder insulin for the treatment of diabetes mellitus.
Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
[TBL] [Abstract][Full Text] [Related]
16. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
17. Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
Gross JL; Nakano M; Colon-Vega G; Ortiz-Carasquillo R; Ferguson JA; Althouse S; Tobian JA; Berclaz PY; Milicevic Z
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S27-34. PubMed ID: 19772446
[TBL] [Abstract][Full Text] [Related]
18. Insulin lispro: a fast-acting insulin analog.
Noble SL; Johnston E; Walton B
Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
[TBL] [Abstract][Full Text] [Related]
19. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
Pham DQ; Cohen H; Chu V
J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
[TBL] [Abstract][Full Text] [Related]
20. Treatment of type 1 diabetes with insulin lispro during Ramadan.
Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
